Table 3. The association study of rs12970134 and rs17782313 with obesity-related phenotypes.

	rs12970134				rs17782313
	n	Estimate (95%CI) a	P-value a	P-value b	n	Estimate (95%CI) a	P-value a	P-value b
Height(cm)	2169	0.28(-0.22, 0.79)	0.274	-	2030	0.54(0.04, 1.03)	0.035	-
Weight(kg)	2169	0.88(-0.09, 1.85)	0.074	-	2030	0.40(-0.53, 1.32)	0.399	-
BMI-SDS	2169	0.07(-0.13, 0.14)	0.100	-	2030	0.03(-0.40, 0.11)	0.361	-
Waist circumference(cm)	2156	0.73(-0.06, 1.52)	0.070	0.744	2017	0.24(-0.50, 0.98)	0.521	0.476
Hip circumference(cm)	2154	0.66(0.04, 1.28)	0.038	0.783	2015	0.31(-0.28, 0.90)	0.299	0.134
Waist-to-Hip Ratio	2154	0.002(-0.002, 0.01)	0.333	0.634	2015	0.002(-0.002, 0.002)	0.911	0.856
Total Cholestestrol(mmol/L)	2169	-0.03(-0.09, 0.02)	0.242	0.126	2030	-0.03 (-0.097, 0.02)	0.190	0.172
Triglyceride(mmol/L)	2169	0.03(-0.01,0.07)	0.152	0.456	2030	-0.01(-0.05, 0.02)	0.472	0.363
LDL-C(mmol/L)	2169	0.01(-0.04, 0.06)	0.728	0.683	2030	0.002(-0.047, 0.051)	0.943	0.962
HDL-C(mmol/L)	2169	-0.03(-0.06, -0.01)	0.002	0.013	2030	-0.02 (-0.03, 0.003)	0.107	0.119
Systolic BP(mmHg)	2159	0.6(-0.40, 1.56)	0.237	0.941	2021	0.30(-0.64, 1.24)	0.533	0.602
Diastolic BP(mmHg)	2159	1.07(-0.19, 2.34)	0.096	0.329	2021	0.62(-0.43, 1.67)	0.245	0.265
Fasting glucose(mmol/L)	2169	-0.01(-0.05, 0.03)	0.653	0.861	2030	-0.01(-0.04, 0.03)	0.741	0.719
Body fat percentage (%)	1061	0.70(0.002, 1.40)	0.049	0.428	1071	0.36(-0.32, 1.05)	0.298	0.896
Metabolic syndrome	2153	1.05(0.90–1.23)	0.523	0.596	2015	0.91(0.77–1.06)	0.210	0.168

BMI, body mass index; BMI-SDS, BMI standard deviation score; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; BP, blood pressure; CI, confidence interval.

^a Effect sizes and P-values were calculated adjusted for age, sex and study groups.

^b P-values were calculated additionally adjusted for BMI.